Literature DB >> 26243491

Categorising major cardiovascular disease hospitalisations from routinely collected data.

Grace Joshy1, Rosemary J Korda2, Walter P Abhayaratna3, Kay Soga2, Emily Banks4.   

Abstract

UNLABELLED: Objectives and importance of the study: Routine hospital administrative data provide an important source of information about cardiovascular disease (CVD) for health statistics reporting, health services and research. How such conditions are classified and grouped has implications for the use and interpretation of these data. International Classification of Diseases (ICD) diagnosis codes from hospital data collections are often used to classify CVD, but there is little published evidence on the most appropriate ways to use these codes to categorise CVD in a way that maximises the usefulness of hospital data for reporting and research. In particular, ICD codes under 'Diseases of the circulatory system' (I00-I99) are often grouped together into a general CVD category. However, this category is heterogeneous and combines common severe atherosclerotic and thrombotic CVDs (such as myocardial infarction and pulmonary embolism) with common, less severe and pathologically dissimilar conditions (such as varicose veins and haemorrhoids). In addition, hospital data collections contain a range of data fields, including those relating to primary and additional diagnoses and those relating to procedures. All of these have the potential to contribute valuable information on CVD. This paper proposes a pragmatic approach to using ICD diagnosis codes and procedure codes to capture major atherosclerotic and arteriovenous thromboembolic and related CVD.
METHODS: We reviewed the ICD diagnosis codes and procedure codes and developed an algorithm for classifying and categorising major CVD diagnoses. This approach was then applied to linked hospitalisation data from individuals participating in the 45 and Up Study, a cohort study of 267 153 New South Wales residents aged 45 and over, to investigate the implications of the proposed approach for quantifying CVD.
RESULTS: Large differences were observed in the numbers of events in grouped CVD outcomes, depending on the methods used.
CONCLUSIONS: In cases where the reporting and research interest relates to incident disease, it may be appropriate to prioritise specific disease categories and pathological homogeneity.

Entities:  

Mesh:

Year:  2015        PMID: 26243491     DOI: 10.17061/phrp2531532

Source DB:  PubMed          Journal:  Public Health Res Pract        ISSN: 2204-2091


  10 in total

1.  External Validation of the Hospital Frailty-Risk Score in Predicting Clinical Outcomes in Older Heart-Failure Patients in Australia.

Authors:  Yogesh Sharma; Chris Horwood; Paul Hakendorf; Rashmi Shahi; Campbell Thompson
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

2.  Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study.

Authors:  Rosemary J Korda; Kay Soga; Grace Joshy; Bianca Calabria; John Attia; Deborah Wong; Emily Banks
Journal:  Int J Equity Health       Date:  2016-11-21

3.  Variation in readmission and mortality following hospitalisation with a diagnosis of heart failure: prospective cohort study using linked data.

Authors:  Rosemary J Korda; Wei Du; Cathy Day; Karen Page; Peter S Macdonald; Emily Banks
Journal:  BMC Health Serv Res       Date:  2017-03-21       Impact factor: 2.655

4.  Breastfeeding and Cardiovascular Disease Hospitalization and Mortality in Parous Women: Evidence From a Large Australian Cohort Study.

Authors:  Binh Nguyen; Joanne Gale; Natasha Nassar; Adrian Bauman; Grace Joshy; Ding Ding
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

5.  Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study.

Authors:  Emily Banks; Grace Joshy; Rosemary J Korda; Bill Stavreski; Kay Soga; Sam Egger; Cathy Day; Naomi E Clarke; Sarah Lewington; Alan D Lopez
Journal:  BMC Med       Date:  2019-07-03       Impact factor: 8.775

6.  Does psychological distress directly increase risk of incident cardiovascular disease? Evidence from a prospective cohort study using a longer-term measure of distress.

Authors:  Jennifer Welsh; Emily Banks; Grace Joshy; Peter Butterworth; Lyndall Strazdins; Rosemary J Korda
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

7.  Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study.

Authors:  Yogesh Sharma; Chris Horwood; Paul Hakendorf; Campbell Thompson
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

8.  Is poor oral health a risk marker for incident cardiovascular disease hospitalisation and all-cause mortality? Findings from 172 630 participants from the prospective 45 and Up Study.

Authors:  Grace Joshy; Manish Arora; Rosemary J Korda; John Chalmers; Emily Banks
Journal:  BMJ Open       Date:  2016-08-30       Impact factor: 2.692

9.  Trends in Frailty and Use of Evidence-Based Pharmacotherapy for Heart Failure in Australian Hospitalised Patients: An Observational Study.

Authors:  Yogesh Sharma; Chris Horwood; Paul Hakendorf; Campbell Thompson
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

10.  Different Types of Long-Term Milk Consumption and Mortality in Adults with Cardiovascular Disease: A Population-Based Study in 7236 Australian Adults over 8.4 Years.

Authors:  Xiaoyue Xu; Alamgir Kabir; Margo L Barr; Aletta E Schutte
Journal:  Nutrients       Date:  2022-02-08       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.